- NPMI

Muscat Securities Market (Sultanat of Oman)
0.19 Last Update 22/01/2019 14:49 KSA
× lblWarning! {{companyMessage}}
  • :0.19
  • :0.19
  • ('000):50,000
  • (OMR '000):9,450
  • :-0.07


  • 0
  • :490
  • :0
  • 52-W L52-W H
    0.19
    0.00000.2
  • 5.50%
  • -


  • 0

  • (OMR):

    0
  • (OMR):93
  • :0
  • Performance Comparison

Activities

National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.

  • Chairman:
    Ghazi O. Al Zubeidi
  • Vice-chairman:
    Abdullah M. B. Al Qenaei
  • CEO:
    G . Sridhar
  • Board Members:

    Amal S. Bahwan

    Khalifa S. Al Mohannadi

    Mahmoud A. Zubaid

    Omar S. Bahwan

  • Auditors:

    Moore Stephens

CMA clears OMR5m rights issue of National Pharmaceuticals (Times of Oman - 24/12/2017)

National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
15/10/2018 9-Month 30/09/2018 01 25
12/04/2018 3-Month 31/03/2018 00 16.39
14/01/2018 12-Month 31/12/2017 02 21.33
12/10/2017 9-Month 30/09/2017 01 7.05
12/07/2017 6-Month 30/06/2017 01 -9.96
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 2,070.71 77.1 -0.78 -5.24 20.81 2.8 1.92 0.79 13.85 22.49
DALLAHHEALTH 1,003.16 65.7 2.97 -41.42 21.83 2.32 3.92 0.92 12.1 17.53
SPIMACO 930.62 29 -0.35 -6.85 26.93 1.32 3.41 0.9 8.47 15.11
MEAHCO 810.67 32.5 -1.67 -42.72 13.86 1.86 5.98 0.8 11.92 18.76
JULPHAR 636.83 2.07 -0.49 -14.4 29.46 1.01 5.27 0.21 4.09 0
CARE 562.96 46.3 -1.7 0.64 26.22 2.19 2.11 0.86 -0.59 -0.89
MCGS 507.71 65.4 -1.29 -18.01 22.07 1.86 5.93 0.97 6.76 7.99
ATC.KSE 492.15 1,000 0 -9.09 16.79 3.04 1.82 -0.01 2.93 12.88
GMPC 332.93 1.7 -2.86 -12.5 27.69 0.93 3 -0.07 75.81 111.42
YIACO 57.48 105 9.03 -44.97 -14.42 1.79 0 0.11 -8.47 -63.6
NPMI 24.5 0.19 0 67.26 5.05 1.2 11.67 -0.07 6.11 0
QGMD 19.91 6.2 -2.06 -0.94 -3.5 1.06 0 0.79 -6.18 0